Breaking News

Cobra Biologics Gains Approval for R&D Tax Credit

Offers R&D incentive for French companies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cobra Biologics has been recognized by the French Ministry of Higher Education and Research (MESR) as an approved service provider for its antibody and recombinant protein services for the period 2013 to 2015. The approval allows French companies that outsource their R&D programs to Cobra’s centre of excellence, to receive a research tax credit.   The tax credit, which covers 30% of all R&D expenses up to €100 million, and 5% above this threshold, aims to encourage R&D efforts and en...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters